Eu Yan Sang to be delisted in October
TRADITIONAL Chinese medicine retailer Eu Yan Sang will request a suspension of trading in its shares starting Sept 28 and delist on Oct 7, it said in a Singapore Exchange (SGX) filing on Tuesday.
The delisting spells an end to the group's 16 years on the SGX main board.
It comes after a consortium led by a UOB-backed fund, a Temasek Holdings unit and Eu Yan Sang International's group chief executive officer Richard Eu made a privatisation bid for the company, offering S$0.60 cash for each share that it does not own.
The final closing date for the offer was Sept 27. Eu Yan Sang shares closed a cent higher at S$0.60 on Tuesday.
Share with us your feedback on BT's products and services
TRENDING NOW
Grab CEO’s wife Chloe Tong on life with Anthony Tan and finding her purpose
Hwa Seng Builder, two China companies win S$1.2 billion Tuas Road Viaduct phase two contracts
Deal between tycoon friends sparks scrutiny of Philippine power sector
Canada is upping oil flows to Asia, but South-east Asia’s refineries aren’t ready to handle them yet